Losic, Bojan
Craig, Amanda J.
Villacorta-Martin, Carlos
Martins-Filho, Sebastiao N.
Akers, Nicholas
Chen, Xintong
Ahsen, Mehmet E. http://orcid.org/0000-0002-4907-0427
von Felden, Johann http://orcid.org/0000-0003-2839-5174
Labgaa, Ismail http://orcid.org/0000-0003-4286-2170
DʹAvola, Delia
Allette, Kimaada
Lira, Sergio A.
Furtado, Glaucia C.
Garcia-Lezana, Teresa http://orcid.org/0000-0002-7863-6784
Restrepo, Paula
Stueck, Ashley
Ward, Stephen C.
Fiel, Maria I.
Hiotis, Spiros P.
Gunasekaran, Ganesh
Sia, Daniela
Schadt, Eric E. http://orcid.org/0000-0002-7892-8808
Sebra, Robert
Schwartz, Myron http://orcid.org/0000-0002-9113-886X
Llovet, Josep M. http://orcid.org/0000-0003-0547-2667
Thung, Swan
Stolovitzky, Gustavo
Villanueva, Augusto http://orcid.org/0000-0003-3585-3727
Article History
Received: 17 January 2019
Accepted: 13 December 2019
First Online: 15 January 2020
Competing interests
: A.V. received consulting fees from Guidepoint and Fujifilm; advisory board fees from Exact Sciences, Nucleix and NGM Pharmaceuticals; and lecture fees from Exelixis. J.M.L. is receiving research support from Bayer HealthCare Pharmaceuticals, Eisai Inc, Bristol-Myers Squibb, Boehringer-Ingelheim and Ipsen, and consulting fees from Eli Lilly, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb, Eisai Inc, Celsion Corporation, Exelixis, Merck, Ipsen, Roche, Genentech, Glycotest, Navigant, Leerink Swann LLC, Midatech Ltd, Fortress Biotech, Sprink Pharmaceuticals, Nucleix and Can-Fite Biopharma. The remaining authors declare no competing interests.